Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
2
Frequently Asked Questions
What is Market Cap of Bone Biologics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bone Biologics Corp market cap is $5.01M.
What is the 52-week high for Bone Biologics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bone Biologics Corp 52 week high is $13.80 as of October 02, 2025.
What is the 52-week low for Bone Biologics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bone Biologics Corp 52 week low is $1.95 as of October 02, 2025.
What is Bone Biologics Corp stock price today?
Bone Biologics Corp stock price today is $2.79.
What was Bone Biologics Corp stock price yesterday?
Bone Biologics Corp stock price yesterday was $2.79.
What is the PE ratio of Bone Biologics Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bone Biologics Corp’s P/E ratio is -0.14.
What is the Price-to-Book ratio of Bone Biologics Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Bone Biologics Corp P/B ratio is 0.7128.
What is the 50-day moving average of Bone Biologics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bone Biologics Corp 50-day moving average is $2.38.
